Uroxatral
The active ingredient is developed to alleviate urinary symptoms associated with benign prostatic hyperplasia and is intended to support improved bladder function.
- Category
- Men's Health
- Active ingredient
- Alfuzosin
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Prolonged-release tablet
- Strengths
- 10mg
Uroxatral details
- Condition
- Benign Prostatic Hyperplasia
- Alternative names
- Xatral
- Therapeutic class
- Alpha-adrenoceptor antagonist
- Pharmacological class
- Alpha-blocker
- Minor side effects
- dizziness; fatigue; headache
- Moderate side effects
- postural hypotension; tachycardia; nausea
- Dosage forms
- Prolonged-release tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Sanofi
- Onset Time
- 1–2 hours
- Duration
- 24 hours
- Storage instructions
- Store below 25°C, away from moisture.
- Drug interactions
- ketoconazole; ritonavir; nitrates
- Age restrictions
- Not for use in women or children.
- Pregnancy and breastfeeding
- Not applicable.
Contraindications
hypersensitivity to alfuzosin; history of orthostatic hypotension; severe hepatic impairment; concurrent use of other alpha-blockers
Precautions and warnings
risk of syncope during initial dosing; monitor blood pressure; avoid rapid position changes
Serious side effects
syncope, requires immediate medical attention; severe hypotension, requires immediate medical attention
Patient summary
The active ingredient is developed to alleviate urinary symptoms associated with benign prostatic hyperplasia and is intended to support improved bladder function.
Mechanism of action
Alfuzosin is a selective antagonist of alpha1-adrenoceptors in the prostate. By relaxing the smooth muscle of the prostate and the bladder neck, it reduces the resistance to urinary flow, facilitating easier emptying of the bladder.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Uroxatral
Uroxatral is a medication containing the active ingredient alfuzosin, designed to address symptoms associated with benign prostatic hyperplasia. Often recognized by the brand name Xatral, this treatment is manufactured by Sanofi and supplied as a 10mg tablet. It serves as a standard option for individuals looking to manage urinary symptoms linked to prostate enlargement.
Buying Uroxatral online
Uroxatral is registered across 13 markets including South Korea, Japan and the UAE, with availability also in Singapore, Hong Kong and Thailand. As a frequently ordered medication across the region, it can be purchased online for delivery to your location. Generic alfuzosin, much of it produced in India, offers a significantly more affordable cost than the original brand, providing reliable access for expats and those residing away from a well stocked pharmacy.